Indice specialistico Infettivologia

Bibliografia Vento S, Garofano T, Renzini C et al. Fulminant hepatitis associated hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med 1998; 338: 286-290. Sagliocca L, Stroffolini T, Amoroso P et al. Risk factors for acute hepatitis B: a case control study. Journal of Viral Hepatitis 1997; 4: 63-66. Sagnelli E, Stroffolini T,Ascione A et al. Decrease in HDV endemicity in Italy. J Hepatol 1997; 26: 20-24. Simmonds P, Mellor J, Craxì A et al. Epidemiological, clinical and therapeutic associations of hepatitis C types in western European patients. J Hepatol 1996; 24: 517-524. Kaur S, Rybicki L, Bacon BR, Gollan JL, Rustgi VK, Carey WD and the National Hepatitis Surveillance Group. Performance Characte ristic and Results of a Large-Scale Screening Program for Viral hepatitis and Risk Factors Associated With Exposure to Viral hepatitis B and C: Results of the National Hepatitis Screening Survey. Hepatology. 1996; 24: 979-986. Bellentani S, Tiribelli C, Saccoccio G, Sodde M, Fratti N, De Martin C, Cristianini G and the Dionysos Study Group. Prevalence of Chronic Liver Disease in the General Population of Northern Italy: The Dionysos Study. Hepatology. 1994; 20:1442-1449. Saracco G, Rizzetto M. A pratical guide to the use of interferons in the management of hepatitis virus infections. Drugs 1997; 53: 74-85. Hoofnagle JH, Di Bisceglie AM. The treatment of chronic viral hepatitis. N. Engl. J. Med. 1997; 336:347-356. Dienstag JL, Perrillo PP, Schiff ER et al. A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 1995; 333: 1704-5. Bain VG, Kneteman NM, Ma MM et al. Efficacy of lamivudine in chronic hepatitis B patients with active viral replication and decompensated cirrhosis undergoing liver transplantation. Transplantation 1996; 62: 1456-62. Grellier L, Mutimer M, Ahmed M et al. Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis. Lancet 1996; 348: 1212-15. Reichard O, Norkrans G, Fryden A et al. Randomised, double-blind,placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. The Lancet 1998; 351: 83-87.